Masterclass Biotechnology – Faculty members

• Eva-Lotta Allan, Chief Business Officer Ablynx 
• Lieven Annemans, Prof. Health Economics I-CHER (UGent, VUB)
• Chris Buyse, CFO ThromboGenics
• Jean-Jacques Cassiman, Prof. Em. KULeuven and President of the Fund for Rare Diseases and Orphan Drugs
• Katrien Decroos, Managing Director Square Circle
• Rudy Dekeyser, Managing Director Vlaams Instituut voor Biotechnologie 
• Ann Dhoore, Human Resources Senior Manager at Amgen Belux 
• Roch Doliveux, Chief Executive Officer UCB
• Bart De Moor, Vice-rector International Policy KULeuven
• France Fannes, General Manager BioWin
• Bruno Flamion, Former Chair of Scientific Advice Working Party, European Medicines Agency (EMA) and chair CRM/CTG
• Ludo Goethals, Managing Partner Square Circle
• Marjorie Gobert, Legal counsel pharma.be
• Annie Hubert,  Director European Government & Public Affairs Amgen International.  
• Frank Landolt, IP and Legal Counsel Ablynx nv
• Ludo Lauwers, Senior Vice-President Janssen Pharmaceutica N.V.
• Marc Martens, Bird & Bird Senior Associate.
• Leo Neels, General Manager pharma.be
• Patrick Van Beneden, Vice President Life Sciences GIMV
• Chris Van Den Broucke, Vice President and Regional Director Amgen International
• Johan Vanhemelrijck, Secretary General Bio.be
• Dirk Van Poucke, Professor ‘Negotiation, competitive decision making and conflict management’ 
• Liesbeth Weynants, Intellectual Property, Public & Regulatory, Dispute Resolution at NautaDutilh